These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 18089450)

  • 1. Relationship between fetuin-A concentration, elevated levels of inflammatory markers, and arterial wall stiffness in end-stage kidney disease.
    Kuźniar J; Porazko T; Klinger M
    J Ren Nutr; 2008 Jan; 18(1):83-6. PubMed ID: 18089450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study on the relationship of serum fetuin-A concentration with aortic stiffness in patients on dialysis.
    Hermans MM; Brandenburg V; Ketteler M; Kooman JP; van der Sande FM; Gladziwa U; Rensma PL; Bartelet K; Konings CJ; Hoeks AP; Floege J; Leunissen KM
    Nephrol Dial Transplant; 2006 May; 21(5):1293-9. PubMed ID: 16396973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-18 is involved in vascular injury in end-stage renal disease patients.
    Porazko T; Kúzniar J; Kusztal M; Kúzniar TJ; Weyde W; Kuriata-Kordek M; Klinger M
    Nephrol Dial Transplant; 2009 Feb; 24(2):589-96. PubMed ID: 18775894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased aortic wall stiffness associated with low circulating fetuin A and high C-reactive protein in predialysis patients.
    Porazko T; Kuźniar J; Kusztal M; Kuźniar TJ; Weyde W; Kuriata-Kordek M; Klinger M
    Nephron Clin Pract; 2009; 113(2):c81-7. PubMed ID: 19602903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations of serum fetuin-A with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients.
    Wang AY; Woo J; Lam CW; Wang M; Chan IH; Gao P; Lui SF; Li PK; Sanderson JE
    Nephrol Dial Transplant; 2005 Aug; 20(8):1676-85. PubMed ID: 15899935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular disease in the dialysis population: prognostic significance of arterial disorders.
    Guérin AP; Pannier B; Marchais SJ; London GM
    Curr Opin Nephrol Hypertens; 2006 Mar; 15(2):105-10. PubMed ID: 16481874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fetuin-A is an independent determinant of change of aortic stiffness over 1 year in non-diabetic patients with CKD stages 3 and 4.
    Ford ML; Tomlinson LA; Smith ER; Rajkumar C; Holt SG
    Nephrol Dial Transplant; 2010 Jun; 25(6):1853-8. PubMed ID: 20075438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac calcifications: Fetuin-A and other risk factors in hemodialysis patients.
    Coen G; Manni M; Agnoli A; Balducci A; Dessi M; De Angelis S; Jankovic L; Mantella D; Morosetti M; Naticchia A; Nofroni I; Romagnoli A; Gallucci MT; Tomassini M; Simonetti G; Splendiani G
    ASAIO J; 2006; 52(2):150-6. PubMed ID: 16557100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with aortic stiffness and its change over time in peritoneal dialysis patients.
    Jung JY; Hwang YH; Lee SW; Lee H; Kim DK; Kim S; Oh YG; Yang J; Joo KW; Ahn C; Oh KH
    Nephrol Dial Transplant; 2010 Dec; 25(12):4041-8. PubMed ID: 20501463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of intradialytic exercise on arterial compliance and B-type natriuretic peptide levels in hemodialysis patients.
    Toussaint ND; Polkinghorne KR; Kerr PG
    Hemodial Int; 2008 Apr; 12(2):254-63. PubMed ID: 18394060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular calcification and fetuin-A deficiency in chronic kidney disease.
    Westenfeld R; Jahnen-Dechent W; Ketteler M
    Trends Cardiovasc Med; 2007 May; 17(4):124-8. PubMed ID: 17482094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus infection as a risk factor for increased aortic stiffness and cardiovascular events in dialysis patients.
    Oyake N; Shimada T; Murakami Y; Ishibashi Y; Satoh H; Suzuki K; Matsumory A; Oda T
    J Nephrol; 2008; 21(3):345-53. PubMed ID: 18587722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular calcification in patients with end-stage renal disease.
    Floege J; Ketteler M
    Nephrol Dial Transplant; 2004 Aug; 19 Suppl 5():V59-66. PubMed ID: 15284362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fetuin-A and arterial stiffness in patients with normal kidney function.
    Roos M; Richart T; Kouznetsova T; von Eynatten M; Lutz J; Heemann U; Baumann M; Staessen JA
    Regul Pept; 2009 Apr; 154(1-3):39-43. PubMed ID: 19110009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum osteoprotegerin level, carotid-femoral pulse wave velocity and cardiovascular survival in haemodialysis patients.
    Speer G; Fekete BC; El Hadj Othmane T; Szabó T; Egresits J; Fodor E; Kiss I; Logan AG; Nemcsik J; Szabó A; Németh ZK; Szathmári M; Tislér A
    Nephrol Dial Transplant; 2008 Oct; 23(10):3256-62. PubMed ID: 18450827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arterial stiffness: a new surrogate end point for cardiovascular disease?
    Laurent S; Boutouyrie P
    J Nephrol; 2007; 20 Suppl 12():S45-50. PubMed ID: 18050143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low serum fetuin-A concentration predicts poor outcome only in the presence of inflammation in prevalent haemodialysis patients.
    Metry G; Stenvinkel P; Qureshi AR; Carrero JJ; Yilmaz MI; Bárány P; Snaedal S; Heimbürger O; Lindholm B; Suliman ME
    Eur J Clin Invest; 2008 Nov; 38(11):804-11. PubMed ID: 19021697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum fetuin a in hemodialysis: a link between derangement of calcium-phosphorus homeostasis and progression of atherosclerosis?
    Pertosa G; Simone S; Ciccone M; Porreca S; Zaza G; Dalfino G; Memoli B; Procino A; Bonomini M; Sirolli V; Castellano G; Gesualdo L; Ktena M; Schena FP; Grandaliano G
    Am J Kidney Dis; 2009 Mar; 53(3):467-74. PubMed ID: 19167798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progressive vascular calcification over 2 years is associated with arterial stiffening and increased mortality in patients with stages 4 and 5 chronic kidney disease.
    Sigrist MK; Taal MW; Bungay P; McIntyre CW
    Clin J Am Soc Nephrol; 2007 Nov; 2(6):1241-8. PubMed ID: 17928470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulse wave velocity in end-stage renal disease: influence of age and body dimensions.
    Kis E; Cseprekál O; Horváth Z; Katona G; Fekete BC; Hrapka E; Szabó A; Szabó AJ; Fekete A; Reusz GS
    Pediatr Res; 2008 Jan; 63(1):95-8. PubMed ID: 18043514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.